Antimicrobial use trends, Israel, 2012 to 2017

Yaakov Dickstein*, Elizabeth Temkin, Debby Ben-David, Yehuda Carmeli, Mitchell J. Schwaber

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Background: In 2012, Israel’s National Center for Infection Control initiated a national stewardship programme that included mandatory annual reporting of antimicrobial use. Here we present nationwide Israeli data for the period 2012 to 2017. Aim: The goal of this study was to detect trends in antimicrobial use in Israel following the introduction of the stewardship programme, as part of an assessment of the programme’s impact. Methods: In this retrospective observational study, data were collected from Israel’s health maintenance organisations (HMOs), acute care hospitals and post-acute care hospitals (PACHs). Acute care hospital data were collected for general medical and surgical wards, and medical/surgical intensive care units (ICUs). Data were converted into defined daily doses (DDD), with use rates presented as DDD per 1,000 insured/day in the community and DDD per 100 patient-days in hospitals and PACHs. Trends were analysed using linear regression. Results: Antimicrobial use decreased across sectors between 2012 and 2017. In the community, the decrease was modest, from 22.8 to 21.8 DDD per 1,000 insured per day (4.4%, p=0.004). In acute care hospitals, antibiotic DDDs per 100 patient-days decreased from 100.0 to 84.0 (16.0%, p=0.002) in medical wards, from 112.8 to 94.2 (16.5%, p=0.004) in surgical wards and from 154.4 to 137.2 (11.1%, p=0.04) in ICUs. Antimicrobial use decreased most markedly in PACHs, from 29.1 to 18.1 DDD per 100 patient-days (37.8%, p=0.005). Conclusion: Between 2012 and 2017, antimicrobial use decreased significantly in all types of healthcare institutions in Israel, following the introduction of the nationwide antimicrobial stewardship programme.

Original languageEnglish
Article number1900022
Issue number34
StatePublished - 22 Aug 2019


Dive into the research topics of 'Antimicrobial use trends, Israel, 2012 to 2017'. Together they form a unique fingerprint.

Cite this